Bank Julius Baer & Co
BEAM icon

Bank Julius Baer & Co’s Beam Therapeutics BEAM Stock Holding History

Bank Julius Baer & Co’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.7K Hold
1,710
– – ﹤0.01% 609
2025
Q4 		$47.4K Buy
+1,710
New +$43.6K ﹤0.01% 588
2022
Q2 		– Sell
-2,653
Closed -$152K – 601
2022
Q1 		$152K Buy
+2,653
New +$174K ﹤0.01% 449
2021
Q2 		– Sell
-13,268
Closed -$1.06M – 822
2021
Q1 		$1.06M Buy
+13,268
New +$1.26M 0.01% 332

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Bank Julius Baer & Co's BEAM Position: Q1 2026 in Review

Bank Julius Baer & Co held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 1,710 shares worth $40.7K. The position accounts for ﹤0.01% of the portfolio, ranked #609.

Bank Julius Baer & Co first reported a position in BEAM in Q1 2021 and has held it in 4 quarters since. The position peaked at $1.06M in Q1 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Bank Julius Baer & Co held 1,710 shares of Beam Therapeutics worth $40.7K as of Q1 2026.
  • Bank Julius Baer & Co left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q1 2026, its #609 holding.
  • Bank Julius Baer & Co first reported a position in Beam Therapeutics in Q1 2021 and has held it in 4 quarters since.
  • Bank Julius Baer & Co's Beam Therapeutics position peaked at $1.06M in Q1 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.